Organoid test to guide osteosarcoma treatment
Part of Cancer clinical trials.
This trial uses a lab-grown mini tumor (organoid) from your biopsy to test which drugs might work best for your osteosarcoma. It aims to personalize your treatment based on how your specific cancer cells respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have imaging that suggests osteosarcoma and are scheduled for a biopsy or surgery to confirm it.
- Your imaging suggests the cancer may have spread (metastatic) and you are scheduled for a biopsy or surgery.
- You are willing to have a small piece of your tumor used to grow an organoid in the lab for drug testing.
- You have not yet started treatment for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the immune environment of osteosarcoma tumors to find more personalized treatments. It may help researchers understand why some treatments work better for certain patients.
This trial tests a new drug called OMO-103, which targets a protein called Myc that helps cancer cells grow. It is for people with advanced osteosarcoma (bone cancer) that has worsened after standard chemotherapy. The drug is given intravenously (through a vein), and the study will check if it is safe and shrinks tumors.
This trial tests a special dye that targets B7-H3, a protein found on osteosarcoma cells. Before your surgery, the dye is injected and helps surgeons see tumor edges more clearly, so they can remove all of the cancer while saving healthy tissue.
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
This study uses lab-grown tumor models (organoids) from your tissue or fluid sample to find the best treatment for your ovarian cancer.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.